Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Deborah Lenoci
Observed name:
Lenoci, Deborah
Institution:
Fondazione IRCCS Istituto Nazionale dei Tumori
Observed institutions:
Mario Negri Institute for Pharmacological Research,
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda,
Fondazione IRCCS Istituto Nazionale dei Tumori
ORCID:
0000-0002-5958-8035
Observed ORCID:
0000-0002-5958-8035
OpenAlex ID:
A5090525729
Oral cancer in young adults: incidence, risk factors, prognosis, and molecular biomarkers
2024
·
Deborah Lenoci
, Elisa Moresco
, et al.
·
Frontiers in Oncology
·
70
PDF
hacksig: a unified and tidy R framework to easily compute gene expression signature scores
2022
·
Andrea Carenzo
, Federico Pistore
, et al.
·
Bioinformatics
·
29
PDF
Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis
2022
·
Chiara Pesenti
, Luca Beltrame
, et al.
·
European Journal of Cancer
·
28
PDF
MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures
2023
·
Anna Corti
, Loris De Cecco
, et al.
·
Biomarker Research
·
26
Heart Rate in Patients with SARS-CoV-2 Infection: Prevalence of High Values at Discharge and Relationship with Disease Severity
2021
·
Alessandro Maloberti
, Nicola Ughi
, et al.
·
Journal of Clinical Medicine
·
24
PDF
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab
2024
·
Mara Serena Serafini
, Stefano Cavalieri
, et al.
·
Journal for ImmunoTherapy of Cancer
·
18
PDF
Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities
2023
·
Deborah Lenoci
, Carlo Resteghini
, et al.
·
Translational research
·
18
PDF
Longitudinal assessment of plasma EBV-DNA in non-endemic EBV-related nasopharyngeal cancer (NPC): the LEA study
2025
·
Salvatore Alfieri
, Rebecca Romanò
, et al.
·
European Journal of Cancer
·
14
The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disorders
2025
·
Cristina Gurizzan
, Armando G. Licata
, et al.
·
Oral Oncology
·
12
Interplay between MRI radiomics and immune gene expression signatures in oral squamous cell carcinoma
2025
·
Anna Corti
, Deborah Lenoci
, et al.
·
Scientific Reports
·
11
PDF
Biological properties of hypoxia-related gene expression models/signatures on clinical benefit of anti-EGFR treatment in two head and neck cancer window-of-opportunity trials
2022
·
Deborah Lenoci
, Andrea Carenzo
, et al.
·
Oral Oncology
·
8
Ferroptosis-Related Gene Signatures: Prognostic Role in HPV-Positive Oropharyngeal Squamous Cell Carcinoma
2025
·
Deborah Lenoci
, Mara Serena Serafini
, et al.
·
Cancers
·
6
PDF
LAT1 expression in head and neck cancer: a prognostic biomarker with potential relevance for BNCT
2025
·
Stefano Cavalieri
, Imperia Nuzzolese
, et al.
·
Frontiers in Oncology
·
5
PDF
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer
2022
·
Stefano Cavalieri
, Mara Serena Serafini
, et al.
·
Cells
·
3
PDF
Claudin-1 in Head and Neck Squamous Cell Carcinoma
2024
·
Stefano Cavalieri
, Cristiana Bergamini
, et al.
·
Oncology
·
2
Fragmenting the future with FLARE: a comprehensive fragmentomics pipeline based on long-read nanopore sequencing
2026
·
Marica Ficorilli
, Marta Lucchetta
, et al.
·
Frontiers in Genetics
·
1
PDF
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trial
2024
·
Stefano Cavalieri
, Eleonora Bruno
, et al.
·
Frontiers in Oncology
·
1
Abstract 4529: The tumor molecular landscape of nasopharyngeal carcinoma (NPC) in endemic and non endemic areas
2023
·
Deborah Lenoci
, Carlo Resteghini
, et al.
·
Cancer Research
·
1
Immune Cell Engagers and “Masking Immunotherapy” for Solid Tumors: Focus on Head and Neck Cancers
2026
·
Giuseppe Nardo
, Deborah Lenoci
, et al.
·
Cancers
Transcriptomic clustering identifies shared molecular programs across Human Papillomavirus-driven oropharyngeal and cervical carcinomas
2026
·
Colombo, Elena
, Licata, Armando G.
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Abstract 4897: Characterization of the intratumoral microbiota in non endemic EBV associated nasopharyngeal carcinoma
2026
·
Deborah Lenoci
, Federico Rossignoli
, et al.
·
Cancer Research
Abstract 2866: Host-microbe-epigenetic crosstalk: Dissecting the role of microbiome, immune dysregulation, and DNA methylation in squamous cell carcinoma
2026
·
Armando G. Licata
, Cristina Gurizzan
, et al.
·
Cancer Research
Characterization of the Intratumoral Microbiota in Non-Endemic EBV-Related Nasopharyngeal Carcinoma
2026
·
Deborah Lenoci
, Federico Rossignoli
, et al.
·
Radiotherapy and Oncology
Corrigendum to “Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities” [Transl. Res. 265 (2024) 1-16]
2024
·
Deborah Lenoci
, Carlo Resteghini
, et al.
·
Translational research
PDF
Radgess: Preliminary Results of the in Silico Study for Radioresistance Genomic Signatures in Sinonasal Cancers Experimental Models After Particle Therapy
2024
·
Barbara Vischioni
, Fulgini Giorgia
, et al.
·
International Journal of Particle Therapy
Show more works
View as search
Works count:
32
Citation count:
277
H-index:
10
I10-index:
10
Year
Topic
Type